Keep an eye on adenosine: Its role in retinal inflammation

Pharmacol Ther. 2020 Jun:210:107513. doi: 10.1016/j.pharmthera.2020.107513. Epub 2020 Feb 26.

Abstract

Adenosine is an endogenous purine nucleoside ubiquitously distributed throughout the body that interacts with G protein-coupled receptors, classified in four subtypes: A1R, A2AR, A2BR and A3R. Among the plethora of functions of adenosine, it has been increasingly recognized as a key mediator of the immune response. Neuroinflammation is a feature of chronic neurodegenerative diseases and contributes to the pathophysiology of several retinal degenerative diseases. Animal models of retinal diseases are helping to elucidate the regulatory roles of adenosine receptors in the development and progression of those diseases. Mounting evidence demonstrates that the adenosinergic system is altered in the retina during pathological conditions, compromising retinal physiology. This review focuses on the roles played by adenosine and the elements of the adenosinergic system (receptors, enzymes, transporters) in the neuroinflammatory processes occurring in the retina. An improved understanding of the molecular and cellular mechanisms of the signalling pathways mediated by adenosine underlying the onset and progression of retinal diseases will pave the way towards the identification of new therapeutic approaches.

Keywords: Adenosine; Adenosine receptors; Neuroinflammation; Retina.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adenosine / metabolism*
  • Animals
  • Anti-Inflammatory Agents / therapeutic use
  • Humans
  • Inflammation Mediators / metabolism*
  • Ligands
  • Purinergic P1 Receptor Antagonists / therapeutic use
  • Receptors, Purinergic P1 / metabolism*
  • Retina / drug effects
  • Retina / immunology
  • Retina / metabolism*
  • Retinitis / drug therapy
  • Retinitis / immunology
  • Retinitis / metabolism*
  • Signal Transduction

Substances

  • Anti-Inflammatory Agents
  • Inflammation Mediators
  • Ligands
  • Purinergic P1 Receptor Antagonists
  • Receptors, Purinergic P1
  • Adenosine